Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge

GG Bushnell, AP Deshmukh, P den Hollander… - NPJ breast …, 2021 - nature.com
Breast cancer is the most commonly diagnosed cancer in the USA. Although advances in
treatment over the past several decades have significantly improved the outlook for this …

Eo771, is it a Well‐Characterized cell line for mouse Mammary cancer model? limit and uncertainty

A Le Naour, A Rossary, MP Vasson - Cancer medicine, 2020 - Wiley Online Library
Among mouse mammary tumor models, syngeneic cell lines present an advantage for the
study of immune response. However, few of these models are well characterized. The tumor …

STING suppresses bone cancer pain via immune and neuronal modulation

K Wang, CR Donnelly, C Jiang, Y Liao, X Luo… - Nature …, 2021 - nature.com
Patients with advanced stage cancers frequently suffer from severe pain as a result of bone
metastasis and bone destruction, for which there is no efficacious treatment. Here, using …

EO771, the first luminal B mammary cancer cell line from C57BL/6 mice

A Le Naour, Y Koffi, M Diab, D Le Guennec… - Cancer cell …, 2020 - Springer
Background Despite decades of therapeutic trials, effective diagnosis, many drugs available
and numerous studies on breast cancer, it remains the deadliest cancer in women. In order …

[HTML][HTML] Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice

L Landini, M Marini, DSM de Araujo, A Romitelli… - Brain, Behavior, and …, 2023 - Elsevier
Abstract Insulin growth factor-1 (IGF-1), an osteoclast-dependent osteolysis biomarker,
contributes to metastatic bone cancer pain (MBCP), but the underlying mechanism is poorly …

Sclerostin blockade promotes bone metastases of Wnt‐responsive breast cancer cells

T Hiraga, K Horibe, M Koide, T Yamashita… - Cancer …, 2023 - Wiley Online Library
The secreted protein sclerostin is primarily produced by osteocytes and suppresses
osteoblast differentiation and function by inhibiting the canonical Wnt signaling pathway …

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

DK Mondal, C Xie, GJ Pascal… - Proceedings of the …, 2024 - National Acad Sciences
The complex interplay between malignant cells and the cellular and molecular components
of the tumor stroma is a key aspect of cancer growth and development. These tumor–host …

Decorin evokes reversible mitochondrial depolarization in carcinoma and vascular endothelial cells

T Neill, C Xie, RV Iozzo - American Journal of Physiology …, 2022 - journals.physiology.org
Decorin, a small leucine-rich proteoglycan with multiple biological functions, is known to
evoke autophagy and mitophagy in both endothelial and cancer cells. Here, we investigated …

Potential miRNAs for miRNA-based therapeutics in breast cancer

JS Wong, YK Cheah - Non-coding RNA, 2020 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNAs that can post-transcriptionally regulate
the genes involved in critical cellular processes. The aberrant expressions of oncogenic or …

Primary tumor-induced immunity suppresses bone metastases of breast cancer in syngeneic immunocompetent mouse models

T Hiraga, D Nishida, K Horibe - Bone, 2024 - Elsevier
The immune system plays a crucial role in cancer development and progression. More than
a century ago, mouse models showed that primary tumors suppressed the growth of newly …